| Definition and initial validation of a lupus low disease activity state (LLDAS) K Franklyn, CS Lau, SV Navarra, W Louthrenoo, A Lateef, L Hamijoyo, ... Annals of the rheumatic diseases 75 (9), 1615-1621, 2016 | 636 | 2016 |
| Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 19, 1-11, 2017 | 139 | 2017 |
| Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study V Golder, R Kandane-Rathnayake, M Huq, HT Nim, W Louthrenoo, ... The Lancet Rheumatology 1 (2), e95-e102, 2019 | 116 | 2019 |
| Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis G Darmawan, L Hamijoyo, I Hasan Acta Med Indones 49 (2), 136-147, 2017 | 77 | 2017 |
| Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study D Apostolopoulos, R Kandane-Rathnayake, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 2 (1), e24-e30, 2020 | 64 | 2020 |
| Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 18, 1-9, 2016 | 58 | 2016 |
| Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study V Golder, R Kandane-Rathnayake, M Huq, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 1 (2), e103-e110, 2019 | 55 | 2019 |
| The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus CC Mok, L Hamijoyo, N Kasitanon, S Chen, K Yamaoka, K Oku, MT Li, ... The Lancet Rheumatology 3 (7), e517-e531, 2021 | 46 | 2021 |
| The clinical characteristics of systemic lupus erythematosus patients in Indonesia: a cohort registry from an Indonesia-based tertiary referral hospital L Hamijoyo, S Candrianita, AR Rahmadi, S Dewi, G Darmawan, ... Lupus 28 (13), 1604-1609, 2019 | 37 | 2019 |
| Development of the Asia Pacific lupus collaboration cohort R Kandane‐Rathnayake, V Golder, W Louthrenoo, SF Luo, YJ Jan Wu, ... International journal of rheumatic diseases 22 (3), 425-433, 2019 | 37 | 2019 |
| ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study R Kandane-Rathnayake, W Louthrenoo, A Hoi, SF Luo, YJJ Wu, YH Chen, ... Arthritis Research & Therapy 24 (1), 70, 2022 | 33 | 2022 |
| Strong viral associations with SLE among Filipinos ES Vista, MH Weisman, ML Ishimori, H Chen, RL Bourn, BF Bruner, ... Lupus science & medicine 4 (1), e000214, 2017 | 31 | 2017 |
| Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study R Kandane-Rathnayake, V Golder, W Louthrenoo, YH Chen, J Cho, ... The Lancet Rheumatology 4 (12), e822-e830, 2022 | 27 | 2022 |
| Physician global assessment international standardisation consensus in systemic lupus erythematosus: the PISCOS study M Piga, E Chessa, EF Morand, MF Ugarte-Gil, M Tektonidou, ... The Lancet Rheumatology 4 (6), e441-e449, 2022 | 27 | 2022 |
| Pengapuran sendi atau osteoartritis L Hamijoyo Perhimpunan Reumatologi Indonesia, 2007 | 25 | 2007 |
| Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study R Kandane-Rathnayake, W Louthrenoo, V Golder, SF Luo, YJJ Wu, ... Rheumatology 60 (11), 5185-5193, 2021 | 22 | 2021 |
| Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives SV Navarra, ML Ishimori, EA Uy, L Hamijoyo, J Sama, JA James, ... Lupus 20 (5), 537-543, 2011 | 22 | 2011 |
| Cut off point of neutrophil-to-lymphocyte ratio as a marker of active disease in systemic lupus erythematosus AS Firizal, AK Sugianli, L Hamijoyo Lupus 29 (12), 1566-1570, 2020 | 16 | 2020 |
| Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus R Kandane-Rathnayake, JR Kent, W Louthrenoo, SF Luo, YJJ Wu, ... Lupus 28 (14), 1669-1677, 2019 | 16 | 2019 |
| Prevention of infective complications in systemic lupus erythematosus: a systematic literature review for the APLAR consensus statements K Oku, L Hamijoyo, N Kasitanon, MT Li, S Navarra, E Morand, Y Tanaka, ... International Journal of Rheumatic Diseases 24 (7), 880-895, 2021 | 15 | 2021 |
